chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tightness on the chest; chest was hurting and felt like it has been compressed; congested; body aches/ his body is still aching/ body was aching/ achy; headaches; fever/ he has a temperature at 100; tired; felt weak; feeling kind of hot and achy; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL9261, expiry date unknown) via an unspecified route of administration on 20Jan2021 at a single dose on the left arm for COVID-19 immunization. The patient had no medical history and no known allergies. There were no concomitant medications. The patient did not receive medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient received the first dose of BNT162B2 (lot number: EL1284, expiry date unknown) on 29Dec2020, 11:00AM at a single dose on the left arm for COVID-19 immunization. The patient reported he is probably 160 pounds, 5ft 6 inches; he received the second dose of the COVID-19 vaccine on 20Jan2021, while being due for it on 19Jan2021. He explained having body aches, headaches, fever, tired, and felt weak the following morning (21Jan2021, 04:30 AM) and therefore went to the ER. He had blood works and an X-ray done on 21Jan2021 (results unknown) and they said he had no COVID. Today, 22Jan2021, he has a temperature at 100, his body is still aching, the headaches are there along with a tightness on the chest that concerns him. He also described it as his chest was hurting and felt like it has been compressed. Patient asked what to do. He then mentioned that the nearby urgent care had refused to take him because the vaccine is still 'under investigation' and the ER is far away. Patient also reported that he was feeling kind of hot and achy, body was aching on 21Jan2021.Today, 22Jan2021, he was still the same. He got a fever, was congested, and his body is aching. Patient did not received treatment for the events. Outcome of the events 'body aches/ his body is still aching/ body was aching/ achy,' headaches, 'fever/ he has a temperature at 100,' tired, felt weak, 'feeling kind of hot and achy,' and congested was not recovered. Outcome of the other events was unknown. The events body aches/ his body is still aching/ body was aching/ achy,' headaches, 'fever/ he has a temperature at 100,' tired, and felt weak required Emergency room visit and were reported as medically significant.
Pt was experiencing itchy palms and also had pressure in his ears. Pt was red and flushed. Pt also had itching on the back of his head. Epi was administered.
After HPV, TdaP and MCV given the patient had syncopal episode.  The HPV and TdaP were given in her upper arms and the MCV, the last immunization in her buttock.
has the shingles and he got the shot / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient had the shingles and he got the shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Patient received a Moderna Bivalent on 10/10/2022, and then received a Pfizer Bivalent on 04/06/2023
Patient states she developed redness, diffuse swelling and itching in the area she received a tetanus vaccine ~36hrs prior.
Expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.* No concomitant medication was reported. It was reported that vaccine was administered to total of 24 patients including 15 males and 9 females. HCP reported administrations were mostly for booster shots. No side effects reported. No treatment information were reported.
This case was reported by a pharmacist via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were provided as follows: This case was reported via chat. The age at vaccination was not applicable for this report. The age group was not reported but was selected as adult as per vaccine indication. The reporter had consulted a pharmacist at one of his stores reported that SHINGRIX has had more reactions than any vaccine he had given and also reported that, it was kind of a systemic reaction. The reporter stated, they give a lot more of these shots. The reporter abandoned the chat before further information could be obtained. Another adverse event was collected from this healthcare professional previously during the chat (reported by another agent), which had more specific details but was otherwise unrelated to this particular report.
swollen arm, with itching, redness, and a possible  hard lump of good size  that showed up 7 days later
pt recv vax 23JUL97 & 5AUG97 pt devel less than 50 lesions on back, abd & ears;
Headache, Myalgia, Arthralgia, Nausea Vomiting, CHILLS Narrative:
"Too weak to get up"; incredible vertigo; vomiting; severe headache; fatigue; "Slept most of the day"; very sore arm; insomnia; chills; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: er8735) via an unspecified route of administration in the left arm on 08May2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included ehlers-danlos syndrome, postural orthostatic tachycardia syndrome, syndrome, mast cell activation, mast cell activation syndrome, asthma, sensory processing disorder, chronic depression, anxiety, food allergy, topical adhesive allergy, topical adhesive allergy and chronic bronchitis. Concomitant medications included salbutamol (ALBUTEROL), montelukast sodium (SINGULAIR), glucosamine (MANUFACTURER UNKNOWN) and colecalciferol, calcium gluconate, calcium citrate, magnesium citrate, magnesium gluconate, potassium chloride, sodium chloride (SALTSTICK) and D(unspecified); all taken for unknown indication on an unknown date. The patient previously took Ancef, Advair and experienced drug allergy. The patient previously took Xylitol and experienced allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: er8727) via an unspecified route of administration in the left arm on 14Apr2021 at 13:00( at the age of 40-years-old) as a single dose for COVID-19 immunisation and experienced soreness and (more) and fatigue (than normal). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09May2021, Second shot day 1, the patient experienced very sore arm, insomnia, chills. On 10May2021, Second shot day 2-she was too weak to getup, incredible vertigo, vomiting, chills, severe headache and fatigue. Slept most of the day. Unable to keep her POTS/MCAS food & drink intake schedule. Second shot day 3-vertigo, vomiting, chills, severe headache, fatigue. Drank at least a gallon but didn't eat enough. Second shot day 4-less vertigo, chills, moderate-severe headache, fatigue. Drank at least a gallon + all salt needed but didn't eat enough. Second shot day 5/6-less vertigo, chills, moderate headache and fatigue. Second shot day 7-finally she could get out of bed without severe vertigo, chills and moderate headache. The patient did not receive any treatment for the events reported. The clinical outcome of the event very sore arm, insomnia, chills, "too weak to get up", incredible vertigo, vomiting, severe headache, slept most of the day and fatigue was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Extreme cold developed within 5 days of vaccination. Lasted for about 3 weeks, progressing from chest cold to sore throat to waterfall head cold. First cold in 7-8 yrs after my moving to Calif.  Flu vac each yr prior no reaction.
Pityriasis-like cutaneous eruption that began ~2 weeks post vaccination, continues to spread over about 2/3 of body.
After receipt of vaccine, patient felt faint as he was sitting down in waiting area.  Subsequently fainted and was taken to the emergency department for evaluation
Dizziness, body ache (especially back and neck) lasting a full day, fever/chills overnight, headache, swollen glands.
I felt so fatigue and nauseated; My body was sore, my joints was sore; I felt so fatigue and nauseated; Got this pain in my back on my right shoulders; it hurts when I breathe, I felt like it is down in my muscles; I am in pain I mean my shoulder blade it's hurting and it hurts when I take deep breath; This is a spontaneous report from a contactable consumer. This 67-year-old female consumer (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6199) via an unspecified route of administration on 12Mar2021 (at 67-year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included high blood pressure and asthma. Patient was taking blood pressure medication and she does not remember it. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date (at 67-year-old), as dose 1, single for COVID-19 immunization. No investigation assessment was performed. On 13Mar2021 she felt so fatigue and nauseated, her body was sore, my joints were sore and everything and she took Tylenol and stuff yesterday and then today she still felt little fatigue and on an unknown date in Mar2021 she got this pain in her back on her right shoulders, her back on the right side, upper back. She thought it was her asthma (Clarified as other medical condition) but it was not because I took out my asthma medicine and stuff and it hurt when she breathes, she felt like it was down in her muscles. She had none of this before I had that vaccine, this was the second one. The patient had not recovered.  Consumer was provided with the number of Pfizer Medical Information Department.  No follow-up attempts were possible. No further information was expected.
Information has been received from a pharmacist concerning a 73 year old female who on 31-OCT-2008 was vaccinated with one dose of ZOSTAVAX, Lot number 663195/1416X. On 01-OCT-2008, the patient was vaccinated with influenza virus vaccine (unspecified) and it was unspecified if the patient was on other medications. It was reported that "over the weekend" on approximately 01-NOV-2008 the patient developed swelling at the injection site and rash on her left breast. Also, her lymph nodes were swollen. The pharmacist had not seen the patient. At the time of the report the patient had not contacted her physician yet. At the time of the report the patient was recovering. The patient sought medical attention, called pharmacist. Additional information has been requested.
virus attacked the spinal cord strip the Myelin sheath on the nerves in spinal cord at T5, T6; I am getting feeling, starting to sweat; I became a paraplegic in 1988/I am slowly getting better.; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "paraplegic", start date: 1988 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: SPINAL CORD DISORDER (medically significant), outcome "unknown", described as "virus attacked the spinal cord strip the Myelin sheath on the nerves in spinal cord at T5, T6"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "I am getting feeling, starting to sweat"; THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "I became a paraplegic in 1988/I am slowly getting better.". Clinical course: Patient would like to speak to someone about the fact that since patient had been receiving the COVID-19 vaccinations (all Pfizer) patient was slowly getting better. Patient became a paraplegic in 1988. Virus jumped Species they bought some calves from a neighboring farm that had an outbreak that was causing the animals to become paralyzed. So a virus attacked the spinal cord strip the Myelin sheath on the nerves in spinal cord at T5, T6. Patient was getting feeling, starting to sweat. Patient needed more shots or treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 44-year) on 26Jul2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 26Jul2021 the patient experienced diarrhea, soreness of arms, swelling of underarm (arm where she got injected) that has a knot and feels warm, swollen lymph nodes. It was reported that the patient reported diarrhea, soreness of the arm, swelling under the arm that was injected after receiving her first dose of the Pfizer COVID-19 vaccine. The caller clarified that there was a knot under the arm that feels warm and said that it was a swollen lymph node. The caller also reported that her son also experienced swollen lymph nodes after he received the vaccine same day as her and the patient asked if swollen lymph node was one of the side effects of Pfizer COVID-19 vaccine. The clinical outcome of the events was unknown.  Information about lot/batch number has been requested.
Soreness around injection site, resolved in 6 hours; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness around injection site, resolved in 6 hours) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 010M22A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Cephalexin).   On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (Soreness around injection site, resolved in 6 hours). On 03-Jan-2021, INJECTION SITE PAIN (Soreness around injection site, resolved in 6 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. Concomitant medication includes High Blood Pressure Medication       Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow-up received contains No new information
COLD FEELING AND DIZZY, BLOOD PRESSURE 198/95 PULSE 119  NO RASH, SWELLING OR DIFFICULTY I N BREATHING.  PARAMEDICS CAME AND TOOK HER TO HOSPITAL
Arm tenderness; This is a spontaneous report from a non-contactable healthcare professional. A 26-year-old female patient started received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EK9231, expiry date not reported), via an unspecified route of administration on the right arm on 28Dec2020 16:00 at a single dose for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. The patient experienced arm tenderness on 28Dec2020. No therapeutic measure was taken as a result of the event. Clinical outcome of the event was recovering.    No follow-up attempts are possible. No further information is expected.
Received Covid vaccination and then went into severe bradycardia (pulse=50) with fatigue and reduced exercise tolerance.  No previous history of heart disease or bradycardia.  Patient saw cardiologist.  Scheduled for pacemaker placement.
Patient stated everything was ok until 2/17/2021 when the injection site became warm. swollen and painful. No other reactions were reported by patient
Information has been received from a physician via a company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, or concomitant medications were not reported. On 28-FEB-2014, the patient was vaccinated with a dose of PNEUMOVAX 23 2.5 ml, five dose vial, (lot number J004332, with an expiration date of 26-SEP-2014) (route and anatomical location of administration were not reported) that was improperly stored. The lowest temperature excursion was of 32 Fahrenheit (F) (0 Celsius) for a total of 72 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. Furthermore, no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
feeling like it takes a while to comprehend things; fatigue; congestion; ongoing redness at the injection site; he felt healthy and normal before getting the shot and now he feels terrible; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 18Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 on 19Mar2021 and had no adverse event. On an unspecified date in Apr2021, since the second dose he reports that he has had fatigue, congestion, feeling like it takes a while to comprehend things and ongoing redness at the injection site. The patient reported frustration because he felt healthy and normal before getting the shot and now, he feels terrible and doesn't know when he will feel better. The patient reported that he didn't want to get the shot, but his daughter coerced him into getting it. The outcome of the events ongoing redness at the injection site and he felt healthy and normal before getting the shot and now he feels terrible was not recovered and other events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
11/15/05 Pt had Pneumonia vaccine administered. 11/17/05 Pt had 3in x 3 in area that is red warm firm to touch with skin tight and shiny. Also Raised dark red irregular edges. noted light red streak radiating toward elbow.  Rx for Keflex, Benadryl and Kenalog 4o given.
hair has been shedding and falling out; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL9266) via an unspecified route of administration, administered in left arm on 25Feb2021 10:00 as single dose for covid-19 immunisation. The patient's medical history included stroke, aneurysm, high blood pressure from an unknown date and unknown if ongoing. The patient previously took statins and experienced allergies. The patient's concomitant medications included telmisartan, amlodipine, omeprazole and aspirin at 81 mg. On 24Apr2021 10:30 AM, the patient experienced hair has been shedding and falling out. Patient reported that from end of Apr2021 through now, her hair has been shedding and falling out. Currently she was taking good hair high power synergistical food supplements, but it still sheds and falls out. Patient was wondering if Pfizer with her medicine has cause an issue and she trying to find out why her hair is shedding since it had never happened in the past. Therapeutic measures were taken as a result of my hair has been shedding and falling out. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a License Practical Nurse (LPN) concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) (route, dose, lot number and expiration date were not provided). Other suspect therapies included a dose of M-M-R II (route, dose, lot number and expiration date were not provided). No other co-suspect therapy was reported. Concomitant medications were not provided. The LPN reported that in approximately 2013, the patient's recent titers were negative for VARIVAX (Merck) and M-M-R II. The patient might had gotten the vaccines in the past but the vaccination record could not be located. At the time of reporting, the outcome the event was unknown. Additional information has been requested.